CXI Healthcare Technology Group Limited Stock: price and insider trades · South Korea
씨엑스아이
No insider purchase over the last 90 days. The latest, by ZHANG DONGXIAN, was filed 16 Jul 2026.
CXI Healthcare Technology Group Limited: what insiders have been doing
CXI Healthcare Technology Group Limited is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 1 November 2025 to 1 November 2026, the disclosure feed for CXI Healthcare Technology Group Limited logged 15 filings by 5 insiders.
Both sides are active: 12 purchases worth €3.2M and 3 sales, from 5 insiders and 2 insiders respectively. The totals do not cover 14 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 4 major shareholders and 1 chief executive. One trade stands out by size: a purchase of €3.2M from Lin Jinsheng, disclosed on 12 March 2026, or 15.1% of market capitalisation.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 15 filings here. Our records for CXI Healthcare Technology Group Limited go back to 2021, with 25 purchases and 8 sales on the open market in total.
The latest purchase dates back some time: it was published 116 days ago, on 16 July 2026.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -34.5%Entry ₩1,081 · Close at T+90 ₩708
- -34.5%Entry ₩1,081 · Close at T+90 ₩708
- -34.5%Entry ₩1,081 · Close at T+90 ₩708
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 1,700,000 sharesKRXDART:20260716000363Canonical exit: 14 Oct 2026 (T+90)
- 1,721,034 sharesKRXDART:20260716000358Canonical exit: 14 Oct 2026 (T+90)
- 2,302,289 sharesKRXDART:20260716000339Canonical exit: 14 Oct 2026 (T+90)
- 2,302,289 sharesShareKRXDART:20260716000345Canonical exit: 14 Oct 2026 (T+90)
- 1,700,000 sharesShareKRXDART:20260716000366Canonical exit: 14 Oct 2026 (T+90)
- 1,721,034 sharesShareKRXDART:20260716000359Canonical exit: 14 Oct 2026 (T+90)
- 3,700,000 sharesShareKRXDART:20260617000448Canonical exit: 15 Sept 2026 (T+90)
- 3,700,000 sharesKRXDART:20260617000446Canonical exit: 15 Sept 2026 (T+90)
- 2,011,178 sharesKRXDART:20260610000503
- 5,421,238 sharesShareKRXDART:20260610000478
- 7,421,238 sharesKRXDART:20260610000469
- 2,513,972 sharesKRXDART:20260316000488Canonical exit: 11 Jun 2026 (T+90)
- 25,000,000 sharesKRXDART:20260312001274Canonical exit: 11 Jun 2026 (T+90)
- 6,776,547 shares@ ₩763.79315.10% mcap100.0% of flowShareKRXDART:20260312001162Canonical exit: 20 Nov 2025 (T+90)
- 6,776,547 sharesKRXDART:20260312001139Canonical exit: 11 Jun 2026 (T+90)
25 of 63 declarations
About CXI Healthcare Technology Group Limited
씨엑스아이 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
